NiaHealth provides an end-to-end proactive health platform combining clinical-grade biomarker testing, integrations with consumer wearables, continuous glucose monitoring, and 1:1 clinician guidance to help members identify and act on health risks before symptoms appear. The company offers HSA-eligible services and is available across provinces including Ontario, Alberta, British Columbia, Manitoba, Saskatchewan, Nova Scotia, New Brunswick, Newfoundland and Labrador, and Prince Edward Island. Since emerging from stealth earlier this year it has built a waitlist of over 12,000 Canadians, is on track to cross 300K+ biomarker tests by year-end, and has grown users ~30% month-over-month driven largely by referrals. Platform 2.0, launching this summer, expands testing from ~50 to 100+ biomarkers, adds toxic heavy metals, omegas and advanced thyroid tests, and deepens wearable and CGM integrations. The company plans continued product R&D into predictive features and development of human-first, AI-supported clinician tools while scaling user expansion across Canada. Partnerships with the University of Alberta and corporate customers like Ada support its scientific research and employer benefits programs.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2025